The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(biphenyl-4-ylmethyl)-3-(methoxymethyl)-1H-indole-2-sulfonamide ID: ALA4513527
PubChem CID: 66546714
Max Phase: Preclinical
Molecular Formula: C23H22N2O3S
Molecular Weight: 406.51
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COCc1c(S(=O)(=O)NCc2ccc(-c3ccccc3)cc2)[nH]c2ccccc12
Standard InChI: InChI=1S/C23H22N2O3S/c1-28-16-21-20-9-5-6-10-22(20)25-23(21)29(26,27)24-15-17-11-13-19(14-12-17)18-7-3-2-4-8-18/h2-14,24-25H,15-16H2,1H3
Standard InChI Key: DZDVZXNVKSJSHQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
34.3839 -2.6951 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.3881 -3.5123 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
35.0937 -3.1001 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.8909 -3.1201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8897 -3.9397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5978 -4.3486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5960 -2.7113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3046 -3.1165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3094 -3.9397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0938 -4.1895 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.5738 -3.5207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0860 -2.8577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8038 -4.2212 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.6209 -4.2163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0337 -4.9216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6283 -5.6301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0404 -6.3349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8585 -6.3306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2627 -5.6155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8483 -4.9136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2729 -7.0328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8677 -7.7438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2808 -8.4480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0988 -8.4425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5021 -7.7269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0867 -7.0256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3340 -2.0790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1323 -1.9044 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.3802 -1.1277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 8 1 0
11 2 1 0
2 13 1 0
13 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
18 21 1 0
12 27 1 0
27 28 1 0
28 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 406.51Molecular Weight (Monoisotopic): 406.1351AlogP: 4.46#Rotatable Bonds: 7Polar Surface Area: 71.19Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.21CX Basic pKa: ┄CX LogP: 4.24CX LogD: 4.23Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.48Np Likeness Score: -0.68
References 1. Greig IR, Baillie GL, Abdelrahman M, Trembleau L, Ross RA.. (2016) Development of indole sulfonamides as cannabinoid receptor negative allosteric modulators., 26 (18): [PMID:27542310 ] [10.1016/j.bmcl.2016.08.018 ]